113 related articles for article (PubMed ID: 6480453)
21. Antitumor activity of nigericin and 5-(N-ethyl-N-isopropyl)amiloride: an approach to therapy based on cellular acidification and the inhibition of regulation of intracellular pH.
Hasuda K; Lee C; Tannock IF
Oncol Res; 1994; 6(6):259-68. PubMed ID: 7865901
[TBL] [Abstract][Full Text] [Related]
22. Sequencing of trimodality therapy [cis-diamminedichloroplatinum(II)/hyperthermia/radiation] as determined by tumor growth delay and tumor cell survival in the FSaIIC fibrosarcoma.
Herman TS; Teicher BA
Cancer Res; 1988 May; 48(10):2693-7. PubMed ID: 3359430
[TBL] [Abstract][Full Text] [Related]
23. Mechanism of antitumor activity of tumor necrosis factor alpha with hyperthermia in a tumor necrosis factor alpha-resistant tumor.
Srinivasan JM; Fajardo LF; Hahn GM
J Natl Cancer Inst; 1990 Dec; 82(24):1904-10. PubMed ID: 2250311
[TBL] [Abstract][Full Text] [Related]
24. In vivo response of murine RIF tumors to thermochemotherapy.
Neilan BA; Henle KJ
J Med; 1989; 20(1):107-12. PubMed ID: 2468731
[TBL] [Abstract][Full Text] [Related]
25. Combination and individual antitumor effects of hyperthermia, cisplatin, and selected dithiocarbamates.
Walker EM; Schaefer RF; Henle KJ; Schmidt BJ; Gale GR; Cannon DJ; Jones MM; Moss AJ
Ann Clin Lab Sci; 1989; 19(4):242-54. PubMed ID: 2757352
[TBL] [Abstract][Full Text] [Related]
26. Effects of sequencing of the total course of combined hyperthermia and radiation on the RIF-1 murine tumor.
Mittal B; Emami B; Sapareto SA; Taylor FH; Abrath FG
Cancer; 1984 Dec; 54(12):2889-97. PubMed ID: 6498765
[TBL] [Abstract][Full Text] [Related]
27. Reduction of tumor burden in a murine osteosarcoma following hyperthermia combined with cyclophosphamide.
Hiramoto RN; Ghanta VK; Lilly MB
Cancer Res; 1984 Apr; 44(4):1405-8. PubMed ID: 6584205
[TBL] [Abstract][Full Text] [Related]
28. Significance of additive heat effect in the therapeutic gain factor in combined hyperthermia and radiotherapy: murine tumor response and foot reaction.
Sougawa M; Urano M
Int J Radiat Oncol Biol Phys; 1991 Nov; 21(6):1561-8. PubMed ID: 1938566
[TBL] [Abstract][Full Text] [Related]
29. Synergistic antitumor effect of recombinant adeno-associated virus-mediated pigment epithelium-derived factor with hyperthermia on solid tumor.
Wu Q; He S; Wei X; Shao B; Luo S; Guo F; Zhang H; Wang Y; Gong C; Yang L
Hum Gene Ther; 2014 Sep; 25(9):811-23. PubMed ID: 25003563
[TBL] [Abstract][Full Text] [Related]
30. Defining the pHi-hyperthermia sensitivity relationship for the RIF-1 tumor in vivo: a 31P MR spectroscopy study.
Spees WM; Evelhoch JL; Thompson PA; Sloop DJ; Ackerman JJ
Radiat Res; 2005 Jul; 164(1):86-99. PubMed ID: 15966768
[TBL] [Abstract][Full Text] [Related]
31. Hyperthermia induces doxorubicin release from long-circulating liposomes and enhances their anti-tumor efficacy.
Ning S; Macleod K; Abra RM; Huang AH; Hahn GM
Int J Radiat Oncol Biol Phys; 1994 Jul; 29(4):827-34. PubMed ID: 8040030
[TBL] [Abstract][Full Text] [Related]
32. Combination therapy: lonidamine, hyperthermia, and chemotherapy against the RIF-1 tumor in vivo.
Ning SC; Hahn GM
Cancer Res; 1991 Nov; 51(21):5910-4. PubMed ID: 1718588
[TBL] [Abstract][Full Text] [Related]
33. Induction thermochemotherapy increases therapeutic gain factor for the fractionated radiotherapy given to a mouse fibrosarcoma.
Kuroda M; Urano M; Nishimura Y; Reynolds R
Int J Radiat Oncol Biol Phys; 1997 May; 38(2):411-7. PubMed ID: 9226330
[TBL] [Abstract][Full Text] [Related]
34. Modification of tumor response to cyclophosphamide and irradiation by preirradiation of the tumor bed: prolonged growth delay but reduced curability.
Ito H; Barkley T; Peters LJ; Milas L
Int J Radiat Oncol Biol Phys; 1985 Mar; 11(3):547-53. PubMed ID: 3156110
[TBL] [Abstract][Full Text] [Related]
35. Tumor-specific chemoimmunotherapy of murine fibrosarcoma using tumor-specific transplantation antigen, cyclophosphamide, and interleukin-2.
Naito K; Nomi S; Komichi H; Ueda Y; Yamagishi H; Oka T; Pellis NR; Kahan BD
Cancer Detect Prev; 1992; 16(5-6):321-7. PubMed ID: 1361881
[TBL] [Abstract][Full Text] [Related]
36. Antitumor effects of local hyperthermia on a mouse fibrosarcoma.
Vartak S; George KC; Singh BB
Anticancer Res; 1993; 13(3):727-9. PubMed ID: 8317904
[TBL] [Abstract][Full Text] [Related]
37. The change in hypoxic and chronically hypoxic cell fraction in murine tumors treated with hyperthermia.
Urano M; Kahn J
Radiat Res; 1983 Dec; 96(3):549-59. PubMed ID: 6657921
[TBL] [Abstract][Full Text] [Related]
38. Low-dose cyclophosphamide inhibition of transplantable fibrosarcoma growth by augmentation of the host immune response.
Ray PK; Raychaudhuri S
J Natl Cancer Inst; 1981 Dec; 67(6):1341-5. PubMed ID: 6947115
[TBL] [Abstract][Full Text] [Related]
39. Sequencing of the total course of hyperthermia and irradiation.
Emami B; Mittal BM; Sapareto S
Cancer Res; 1984 Oct; 44(10 Suppl):4731s-4732s. PubMed ID: 6467227
[TBL] [Abstract][Full Text] [Related]
40. Failure to relate the anti-tumour action of cyclophosphamide with the immunogenicity of two murine fibrosarcomas.
Evans R
Int J Cancer; 1978 May; 21(5):611-6. PubMed ID: 659026
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
